Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rema Raman

Showing results (151-160 of 200) with videos related to

Pageof 20
Sort By:
Neurology|April 7, 2017
A phase 3 trial of IV immunoglobulin for Alzheimer diseaseNorman R Relkin, Ronald G Thomas, Robert A Rissman, et al.
Journal of the International Neuropsychological Society : JINS|September 18, 2024
Anxiety in late-life depression is associated with poorer performance across multiple cognitive domainsMaria Kryza-Lacombe, Michelle T Kassel, Philip S Insel, et al.
Psychopharmacology|July 2, 2017
A randomized controlled trial of ganaxolone in posttraumatic stress disorderAnn M Rasmusson, Christine E Marx, Sonia Jain, et al.
The New England Journal of Medicine|July 17, 2023
Trial of Solanezumab in Preclinical Alzheimer's DiseaseReisa A Sperling, Michael C Donohue, Rema Raman, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|September 19, 2025
Accelerated Cognitive Decline in Late Life Depression: The Role of Amyloid-β, Cortico-Limbic Volume, and White Matter HyperintensitiesEmma Rhodes, Philip S Insel, Michelle Kassel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 16, 2022
The AHEAD 3-45 Study: Design of a prevention trial for Alzheimer's diseaseMichael S Rafii, Reisa A Sperling, Michael C Donohue, et al.
JAMA Network Open|March 30, 2026
Amyloid Imaging and APOE Genotype Disclosure and Short-Term Psychological DistressJoshua D Grill, Rema Raman, Shunran Wang, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 26, 2025
Response to "Brain Amyloid and Cognitive Decline in Late-Life Depression"Emma Rhodes, Philip S Insel, Michelle Kassel, et al.
Sleep Advances : a Journal of the Sleep Research Society|October 18, 2021
Brain amyloid burden, sleep, and 24-hour rest/activity rhythms: screening findings from the Anti-Amyloid Treatment in Asymptomatic Alzheimer's and Longitudinal Evaluation of Amyloid Risk and Neurodegeneration StudiesAdam P Spira, Vadim Zipunnikov, Rema Raman, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|April 8, 2026
Relative Impact of Multidomain Lifestyle Interventions on Deficit Accumulation Frailty Over 24 Months in the U.S. POINTER TrialMark A Espeland, KayLoni Olson, Christy C Tangney, et al.
Pageof 20

Showing results (151-160 of 200) with videos related to

Sort By:
Pageof 20
Neurology|April 7, 2017
A phase 3 trial of IV immunoglobulin for Alzheimer diseaseNorman R Relkin, Ronald G Thomas, Robert A Rissman, et al.
Journal of the International Neuropsychological Society : JINS|September 18, 2024
Anxiety in late-life depression is associated with poorer performance across multiple cognitive domainsMaria Kryza-Lacombe, Michelle T Kassel, Philip S Insel, et al.
Psychopharmacology|July 2, 2017
A randomized controlled trial of ganaxolone in posttraumatic stress disorderAnn M Rasmusson, Christine E Marx, Sonia Jain, et al.
The New England Journal of Medicine|July 17, 2023
Trial of Solanezumab in Preclinical Alzheimer's DiseaseReisa A Sperling, Michael C Donohue, Rema Raman, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|September 19, 2025
Accelerated Cognitive Decline in Late Life Depression: The Role of Amyloid-β, Cortico-Limbic Volume, and White Matter HyperintensitiesEmma Rhodes, Philip S Insel, Michelle Kassel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 16, 2022
The AHEAD 3-45 Study: Design of a prevention trial for Alzheimer's diseaseMichael S Rafii, Reisa A Sperling, Michael C Donohue, et al.
JAMA Network Open|March 30, 2026
Amyloid Imaging and APOE Genotype Disclosure and Short-Term Psychological DistressJoshua D Grill, Rema Raman, Shunran Wang, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 26, 2025
Response to "Brain Amyloid and Cognitive Decline in Late-Life Depression"Emma Rhodes, Philip S Insel, Michelle Kassel, et al.
Sleep Advances : a Journal of the Sleep Research Society|October 18, 2021
Brain amyloid burden, sleep, and 24-hour rest/activity rhythms: screening findings from the Anti-Amyloid Treatment in Asymptomatic Alzheimer's and Longitudinal Evaluation of Amyloid Risk and Neurodegeneration StudiesAdam P Spira, Vadim Zipunnikov, Rema Raman, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|April 8, 2026
Relative Impact of Multidomain Lifestyle Interventions on Deficit Accumulation Frailty Over 24 Months in the U.S. POINTER TrialMark A Espeland, KayLoni Olson, Christy C Tangney, et al.
Pageof 20